Company intelligence / Profile preview

Wanjia Group Holdings

Guangzhou/Foshan, Guangdong, Chinawanjialvye.com ↗

Ownership: Private
Employees: ~155
Development stage: Other

Overview

Wanjia Group Holdings is an investment holding company focused on pharmaceutical wholesale/distribution and hemodialysis treatment services in Mainland China. It operates two main segments: Pharmaceutical distribution to retail chains, independent pharmacies, outpatient departments of community hospitals, and healthcare service stations. Hemodialysis treatment centers providing kidney care services. The company has shown growth in its hemodialysis segment but reported financial losses recently.

Therapeutic areas: NephrologyOther
Modalities: Small molecule drugsBiologics
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Wanjia Group Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wanjia Group Holdings.

Explore the full profile